Kazuyoshi Takeda

7PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersMicrobial ecologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 17, 2026
IL-26-driven epigenetic remodeling promotes immune evasion in colorectal cancer.

|Feb 18, 2022
Dietary Lactobacillus-Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy.

Hirotaka Kawanabe-Matsuda, Kazuyoshi Takeda, Marie Nakamura

|Mar 12, 2020
Inhibition of Importin β1 Augments the Anticancer Effect of Agonistic Anti-Death Receptor 5 Antibody in TRAIL-resistant Tumor Cells.

Yuko Kojima, Takashi Nishina, Hiroyasu Nakano

|Jul 24, 2019
Stromal fibroblasts induce metastatic tumor cell clusters via epithelial-mesenchymal plasticity.

Yuko Matsumura, Yasuhiko Ito, Yoshihiro Mezawa

|Mar 24, 2018
Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination.

Kazuyoshi Takeda, Kazutaka Kitaura, Ryuji Suzuki

|Dec 29, 2017
The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion.

Marija Mojic, Kazuyoshi Takeda, Yoshihiro Hayakawa

Pageof 2

Frequent Collaborators

2 joint publications

Takumi Itoh

1 joint publications

Yoshihiro Hayakawa

1 joint publications

Toru Hiraga

1 joint publications

Tomoyuki Yokose